Vol 4 (June 30, 2022): ExRNA

Letter to the Editor 
Persistence of fibrogenic process in direct-acting antiviral (DAA) treated patients?
Cecilia Battistelli, Marco Tripodi
ExRNA  
2022;
4:
15